1FW1.F WUXI BIOLOGICS UNSP.ADR/2

Healthcare Biotechnology Frankfurt Exchange
11.00 EUR
Close of Nov 11, 2026
6.30 13.00
Market cap
EUR 22.6B
P/E
37.9x
P/B
3.56x
ROE
10.4%
Dividend yield
-
Fundamental score
-

Ratios use the latest price and the fiscal year ending Dec 2025.

Is 1FW1.F undervalued?

Graham number
Price11.00
Graham value4.49
Premium144.9%

1FW1.F trades 144.9% above its Graham number.

Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?

WUXI BIOLOGICS UNSP.ADR/2 fundamental analysis

No fundamental analysis for WUXI BIOLOGICS UNSP.ADR/2 yet.

WUXI BIOLOGICS UNSP.ADR/2 stock price

Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.

About WUXI BIOLOGICS UNSP.ADR/2

WuXi Biologics (Cayman) Inc., an investment holding company, provides end-to-end solutions and services for biologics discovery, development, and manufacturing for biologics industry in the People's Republic of China, North America, Europe, Singapore, Japan, South Korea, Australia, and Brazil. It operates through two segments: Biologics and XDC. The company provides a suite of solutions for biologic discovery, from concept to IND, that seamlessly transits to CMC and downstre…

Full company profile